Name | OR-1855 | CAS# | 101328-85-2 | |
---|---|---|---|---|
Price | ¥Inquiry/1g | Purity | 98.9% | |
Stocking Period |
1 Day | Stock | In Stock |
Detail
Product Information
OR-1855, an active metabolite of Levosimendan, has effect on human myometrial contractility. Levosimendan is a calcium sensitiser used in the management of acutely decompensated congestive heart failure. |
Get all suppliers by the below link:
2024-07-15 |
OR-1855
Price: Inquiry |
2019-03-05 |
OR-1855
Price: ¥348.0 |
2020-12-18 |
OR-1855
Price: $Inquiry |
2021-07-26 |
(R)-6-(4-Aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone
Price: $Inquiry |
2022-09-23 |
OR-1855
Price: ¥556.0 |
Get all price from the following link:
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved